Drug Shortage Report for BYSTOLIC

Last updated on 2022-06-30 History
Report ID 156945
Drug Identification Number 02399008
Brand name BYSTOLIC
Common or Proper name Bystolic (nebivolol) tablets
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) NEBIVOLOL
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30s
ATC code C07AB
ATC description BETA BLOCKING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-03-22
Actual start date
Estimated end date 2022-06-30
Actual end date 2022-06-29
Shortage status Resolved
Updated date 2022-06-30
Company comments Bystolic is also available in 2.5mg and 10mg tablets
Health Canada comments
Tier 3 Status No
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2022-06-30 French Compare
v11 2022-06-30 French Compare
v10 2022-06-30 French Compare
v9 2022-06-30 French Compare
v8 2022-06-30 English Compare
v7 2022-06-01 French Compare
v6 2022-06-01 English Compare
v5 2022-03-23 English Compare
v4 2022-03-17 French Compare
v3 2022-03-17 French Compare
v2 2022-03-17 French Compare
v1 2022-03-17 English Compare

Showing 1 to 12 of 12